Psychedelics as potential mental health treatment are explored by Trump administration

Psychedelics as potential mental health treatment are explored by Trump administration

Clinical trials show MDMA and psilocybin offer new hope for treatment-resistant depression and PTSD

Psychedelics research has gained support from the Trump administration for treating PTSD and mental health conditions. (iStock)

In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin to treat mental health disorders. (iStock)

The VA is now opening up to the possibility of psychedelic treatment to promote the health of veterans. (iStock)

Psilocybin is a Schedule I drug under the Controlled Substances Act, but psilocybin-assisted therapy is legal in Oregon, Colorado and New Mexico. (iStock)

The VA currently has 11 psychedelic clinical trials in various phases. (iStock)

Experts emphasize the importance of administering psychedelics in a safe setting when treating mental health conditions. (iStock)